David W. Hutton

10.7k total citations · 1 hit paper
136 papers, 2.8k citations indexed

About

David W. Hutton is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, David W. Hutton has authored 136 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 31 papers in Hepatology and 19 papers in Surgery. Recurrent topics in David W. Hutton's work include Hepatitis B Virus Studies (22 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (13 papers). David W. Hutton is often cited by papers focused on Hepatitis B Virus Studies (22 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (13 papers). David W. Hutton collaborates with scholars based in United States, United Kingdom and China. David W. Hutton's co-authors include Joshua D. Stein, Samuel So, Neehar D. Parikh, Margaret L. Brandeau, Amit G. Singal, Douglas K Owens, Alan M. Garber, Alan S. Go, Paul J. Wang and James V. Freeman and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David W. Hutton

130 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024

2024 67 citations Amadea Britton, Lauren E. Roper et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David W. Hutton United States	28	1.1k	686	422	375	357	136	2.8k
Jobert Richie Nansseu Cameroon	29	866 0.8×	334 0.5×	47 0.1×	549 1.5×	59 0.2×	113	2.9k
Jean Joël Bigna Cameroon	32	1.1k 1.0×	337 0.5×	47 0.1×	666 1.8×	51 0.1×	123	3.5k
Harbir Singh Kohli India	30	504 0.5×	112 0.2×	59 0.1×	180 0.5×	98 0.3×	230	3.3k
Erik J. Dasbach United States	30	2.4k 2.2×	53 0.1×	109 0.3×	361 1.0×	130 0.4×	66	4.4k
Beth H. Shaz United States	43	722 0.7×	172 0.3×	51 0.1×	305 0.8×	76 0.2×	175	6.8k
Francesca J. Torriani United States	32	5.6k 5.1×	4.1k 5.9×	403 1.0×	393 1.0×	155 0.4×	105	7.8k
Marie‐France Mamzer France	35	1.2k 1.1×	540 0.8×	37 0.1×	91 0.2×	96 0.3×	133	3.9k
Gil Melmed United States	43	3.0k 2.8×	184 0.3×	36 0.1×	124 0.3×	108 0.3×	305	7.1k
Diane Aschman United States	7	2.9k 2.6×	445 0.6×	134 0.3×	96 0.3×	41 0.1×	12	7.8k
Georgios K. Nikolopoulos Greece	38	2.0k 1.8×	347 0.5×	21 0.0×	202 0.5×	66 0.2×	212	4.9k

Countries citing papers authored by David W. Hutton

Since Specialization

Citations

This map shows the geographic impact of David W. Hutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Hutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Hutton more than expected).

Fields of papers citing papers by David W. Hutton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Hutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Hutton. The network helps show where David W. Hutton may publish in the future.

Co-authorship network of co-authors of David W. Hutton

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Hutton. A scholar is included among the top collaborators of David W. Hutton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Hutton. David W. Hutton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Toy, Mehlika, David W. Hutton, Eyasu H. Teshale, et al.. (2025). Cost-Effectiveness of One-time Universal Testing for Hepatitis D Among Adults With Chronic Hepatitis B in the United States. Clinical Infectious Diseases. 81(4). e211–e217. 4 indexed citations

Prosser, Lisa A., Grace S. Chung, Acham Gebremariam, et al.. (2025). The cost-effectiveness of vaccination against COVID-19 illness during the initial year of vaccination. Vaccine. 48. 126725–126725. 1 indexed citations

Hutton, David W., Lisa A. Prosser, Angela Rose, et al.. (2024). Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness. PEDIATRICS. 154(6). 10 indexed citations

Hutton, David W., Lisa A. Prosser, Angela M. Rose, et al.. (2024). Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus. Vaccine. 42(24). 126294–126294. 9 indexed citations

Buis, Lorraine R, Ananda Sen, Reema Kadri, et al.. (2024). The Effect of an mHealth Self-Monitoring Intervention (MI-BP) on Blood Pressure Among Black Individuals With Uncontrolled Hypertension: Randomized Controlled Trial. JMIR mhealth and uhealth. 12. e57863–e57863. 3 indexed citations

Hutton, David W., Mehlika Toy, Hanwen Zhang, et al.. (2024). Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States. Journal of Viral Hepatitis. 31(10). 614–622.

Baos, Sarah, Rosie A Harris, David W. Hutton, et al.. (2024). Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV). Trials. 25(1). 39–39. 2 indexed citations

Eisman, Andria B., et al.. (2023). A mixed methods partner-focused cost and budget impact analysis to deploy implementation strategies for school-based prevention. SHILAP Revista de lepidopterología. 4(1). 133–133.

Cheng, Vivian, Mehlika Toy, David W. Hutton, et al.. (2023). Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015–2020. American Journal of Preventive Medicine. 65(1). 52–59. 6 indexed citations

10.

Mahfoud, Felix, Giuseppe Mancia, Krzysztof Narkiewicz, et al.. (2022). Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry. European Heart Journal - Quality of Care and Clinical Outcomes. 9(6). 575–582. 22 indexed citations

11.

Havumaki, Joshua, Joseph N. S. Eisenberg, Claire P. Mattison, et al.. (2021). Immunologic and Epidemiologic Drivers of Norovirus Transmission in Daycare and School Outbreaks. Epidemiology. 32(3). 351–359. 7 indexed citations

12.

Avanceña, Anton L.V., et al.. (2021). Cost‐effectiveness of implantable ventricular assist devices in older children with stable, inotrope‐dependent dilated cardiomyopathy. Pediatric Transplantation. 25(4). e13975–e13975. 1 indexed citations

13.

Schehlein, Emily, et al.. (2021). Detection of Posterior Segment Eye Disease in Rural Eye Camps in South India. Ophthalmology Retina. 5(11). 1107–1114. 2 indexed citations

14.

Liao, Wei‐Ting, David W. Hutton, Qiuji Wu, et al.. (2021). Cost-Effectiveness Analysis of Fourth- or Further-Line Ripretinib in Advanced Gastrointestinal Stromal Tumors. Frontiers in Oncology. 11. 692005–692005. 1 indexed citations

15.

Avanceña, Anton L.V., et al.. (2019). Cost-effectiveness analysis of a physician deployment program to improve access to healthcare in rural and underserved areas in the Philippines. BMJ Open. 9(12). e033455–e033455. 4 indexed citations

16.

Buis, Lorraine R, Reema Kadri, Caroline R. Richardson, et al.. (2018). Improving Blood Pressure Among African Americans With Hypertension Using a Mobile Health Approach (the MI-BP App): Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 8(1). e12601–e12601. 15 indexed citations

17.

Wen, Feng, Hanrui Zheng, Pengfei Zhang, David W. Hutton, & Qiu Li. (2018). OPTIMAL and ENSURE trials-based combined cost-effectiveness analysis of erlotinib versus chemotherapy for the first-line treatment of Asian patients with non-squamous non-small-cell lung cancer. BMJ Open. 8(4). e020128–e020128. 9 indexed citations

18.

Squitieri, Lee, Kevin C. Chung, David W. Hutton, et al.. (2015). A 5-Year Cost-Effectiveness Analysis of Silicone Metacarpophalangeal Arthroplasty in Patients with Rheumatoid Arthritis. Plastic & Reconstructive Surgery. 136(2). 305–314. 7 indexed citations

19.

Hutton, David W., Ravilla D. Ravindran, Aravind Haripriya, et al.. (2014). The Cost of Cataract Surgery at the Aravind Eye Hospital, India. Investigative Ophthalmology & Visual Science. 55(13). 1289–1289. 8 indexed citations

20.

Hutton, David W. & Peter Sheehan. (2011). Comparative effectiveness of the SNaP™ Wound Care System. International Wound Journal. 8(2). 196–205. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact